Report Detail

Request for Sample of this report

Pharma & Healthcare Global OTC Anti-Infective Products Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM3775217
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 91 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
According to our (Global Info Research) latest study, the global OTC Anti-Infective Products market size was valued at US$ 14210 million in 2023 and is forecast to a readjusted size of USD 17820 million by 2030 with a CAGR of 3.3% during review period.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
This report is a detailed and comprehensive analysis for global OTC Anti-Infective Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Sales Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global OTC Anti-Infective Products market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global OTC Anti-Infective Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global OTC Anti-Infective Products market size and forecasts, by Type and by Sales Channel, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2019-2030
Global OTC Anti-Infective Products market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for OTC Anti-Infective Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global OTC Anti-Infective Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, MYLAN, Sun Pharma, CR SANJIU, Cipla, Lingrui, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
OTC Anti-Infective Products market is split by Type and by Sales Channel. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sales Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Market segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe OTC Anti-Infective Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of OTC Anti-Infective Products, with price, sales quantity, revenue, and global market share of OTC Anti-Infective Products from 2019 to 2024.
Chapter 3, the OTC Anti-Infective Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Anti-Infective Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Sales Channel, with sales market share and growth rate by Type, by Sales Channel, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and OTC Anti-Infective Products market forecast, by regions, by Type, and by Sales Channel, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of OTC Anti-Infective Products.
Chapter 14 and 15, to describe OTC Anti-Infective Products sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global OTC Anti-Infective Products Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Antifungal
    • 1.3.3 Antibacterial
    • 1.3.4 Antiviral
    • 1.3.5 Antiseptics
    • 1.3.6 Others
  • 1.4 Market Analysis by Sales Channel
    • 1.4.1 Overview: Global OTC Anti-Infective Products Consumption Value by Sales Channel: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global OTC Anti-Infective Products Market Size & Forecast
    • 1.5.1 Global OTC Anti-Infective Products Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global OTC Anti-Infective Products Sales Quantity (2019-2030)
    • 1.5.3 Global OTC Anti-Infective Products Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Bayer
    • 2.1.1 Bayer Details
    • 2.1.2 Bayer Major Business
    • 2.1.3 Bayer OTC Anti-Infective Products Product and Services
    • 2.1.4 Bayer OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK OTC Anti-Infective Products Product and Services
    • 2.2.4 GSK OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Teva
    • 2.3.1 Teva Details
    • 2.3.2 Teva Major Business
    • 2.3.3 Teva OTC Anti-Infective Products Product and Services
    • 2.3.4 Teva OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Teva Recent Developments/Updates
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson OTC Anti-Infective Products Product and Services
    • 2.4.4 Johnson & Johnson OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Johnson & Johnson Recent Developments/Updates
  • 2.5 NOVARTIS
    • 2.5.1 NOVARTIS Details
    • 2.5.2 NOVARTIS Major Business
    • 2.5.3 NOVARTIS OTC Anti-Infective Products Product and Services
    • 2.5.4 NOVARTIS OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 NOVARTIS Recent Developments/Updates
  • 2.6 MYLAN
    • 2.6.1 MYLAN Details
    • 2.6.2 MYLAN Major Business
    • 2.6.3 MYLAN OTC Anti-Infective Products Product and Services
    • 2.6.4 MYLAN OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 MYLAN Recent Developments/Updates
  • 2.7 Sun Pharma
    • 2.7.1 Sun Pharma Details
    • 2.7.2 Sun Pharma Major Business
    • 2.7.3 Sun Pharma OTC Anti-Infective Products Product and Services
    • 2.7.4 Sun Pharma OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Sun Pharma Recent Developments/Updates
  • 2.8 CR SANJIU
    • 2.8.1 CR SANJIU Details
    • 2.8.2 CR SANJIU Major Business
    • 2.8.3 CR SANJIU OTC Anti-Infective Products Product and Services
    • 2.8.4 CR SANJIU OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 CR SANJIU Recent Developments/Updates
  • 2.9 Cipla
    • 2.9.1 Cipla Details
    • 2.9.2 Cipla Major Business
    • 2.9.3 Cipla OTC Anti-Infective Products Product and Services
    • 2.9.4 Cipla OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Cipla Recent Developments/Updates
  • 2.10 Lingrui
    • 2.10.1 Lingrui Details
    • 2.10.2 Lingrui Major Business
    • 2.10.3 Lingrui OTC Anti-Infective Products Product and Services
    • 2.10.4 Lingrui OTC Anti-Infective Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Lingrui Recent Developments/Updates

3 Competitive Environment: OTC Anti-Infective Products by Manufacturer

  • 3.1 Global OTC Anti-Infective Products Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global OTC Anti-Infective Products Revenue by Manufacturer (2019-2024)
  • 3.3 Global OTC Anti-Infective Products Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of OTC Anti-Infective Products by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 OTC Anti-Infective Products Manufacturer Market Share in 2023
    • 3.4.3 Top 6 OTC Anti-Infective Products Manufacturer Market Share in 2023
  • 3.5 OTC Anti-Infective Products Market: Overall Company Footprint Analysis
    • 3.5.1 OTC Anti-Infective Products Market: Region Footprint
    • 3.5.2 OTC Anti-Infective Products Market: Company Product Type Footprint
    • 3.5.3 OTC Anti-Infective Products Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global OTC Anti-Infective Products Market Size by Region
    • 4.1.1 Global OTC Anti-Infective Products Sales Quantity by Region (2019-2030)
    • 4.1.2 Global OTC Anti-Infective Products Consumption Value by Region (2019-2030)
    • 4.1.3 Global OTC Anti-Infective Products Average Price by Region (2019-2030)
  • 4.2 North America OTC Anti-Infective Products Consumption Value (2019-2030)
  • 4.3 Europe OTC Anti-Infective Products Consumption Value (2019-2030)
  • 4.4 Asia-Pacific OTC Anti-Infective Products Consumption Value (2019-2030)
  • 4.5 South America OTC Anti-Infective Products Consumption Value (2019-2030)
  • 4.6 Middle East & Africa OTC Anti-Infective Products Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global OTC Anti-Infective Products Sales Quantity by Type (2019-2030)
  • 5.2 Global OTC Anti-Infective Products Consumption Value by Type (2019-2030)
  • 5.3 Global OTC Anti-Infective Products Average Price by Type (2019-2030)

6 Market Segment by Sales Channel

  • 6.1 Global OTC Anti-Infective Products Sales Quantity by Sales Channel (2019-2030)
  • 6.2 Global OTC Anti-Infective Products Consumption Value by Sales Channel (2019-2030)
  • 6.3 Global OTC Anti-Infective Products Average Price by Sales Channel (2019-2030)

7 North America

  • 7.1 North America OTC Anti-Infective Products Sales Quantity by Type (2019-2030)
  • 7.2 North America OTC Anti-Infective Products Sales Quantity by Sales Channel (2019-2030)
  • 7.3 North America OTC Anti-Infective Products Market Size by Country
    • 7.3.1 North America OTC Anti-Infective Products Sales Quantity by Country (2019-2030)
    • 7.3.2 North America OTC Anti-Infective Products Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe OTC Anti-Infective Products Sales Quantity by Type (2019-2030)
  • 8.2 Europe OTC Anti-Infective Products Sales Quantity by Sales Channel (2019-2030)
  • 8.3 Europe OTC Anti-Infective Products Market Size by Country
    • 8.3.1 Europe OTC Anti-Infective Products Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe OTC Anti-Infective Products Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific OTC Anti-Infective Products Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific OTC Anti-Infective Products Sales Quantity by Sales Channel (2019-2030)
  • 9.3 Asia-Pacific OTC Anti-Infective Products Market Size by Region
    • 9.3.1 Asia-Pacific OTC Anti-Infective Products Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific OTC Anti-Infective Products Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America OTC Anti-Infective Products Sales Quantity by Type (2019-2030)
  • 10.2 South America OTC Anti-Infective Products Sales Quantity by Sales Channel (2019-2030)
  • 10.3 South America OTC Anti-Infective Products Market Size by Country
    • 10.3.1 South America OTC Anti-Infective Products Sales Quantity by Country (2019-2030)
    • 10.3.2 South America OTC Anti-Infective Products Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa OTC Anti-Infective Products Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa OTC Anti-Infective Products Sales Quantity by Sales Channel (2019-2030)
  • 11.3 Middle East & Africa OTC Anti-Infective Products Market Size by Country
    • 11.3.1 Middle East & Africa OTC Anti-Infective Products Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa OTC Anti-Infective Products Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 OTC Anti-Infective Products Market Drivers
  • 12.2 OTC Anti-Infective Products Market Restraints
  • 12.3 OTC Anti-Infective Products Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of OTC Anti-Infective Products and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of OTC Anti-Infective Products
  • 13.3 OTC Anti-Infective Products Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 OTC Anti-Infective Products Typical Distributors
  • 14.3 OTC Anti-Infective Products Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on OTC Anti-Infective Products. Industry analysis & Market Report on OTC Anti-Infective Products is a syndicated market report, published as Global OTC Anti-Infective Products Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of OTC Anti-Infective Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo